SUBSCRIBE TO OUR FREE NEWSLETTER
Daily news & progressive opinion—funded by the people, not the corporations—delivered straight to your inbox.
5
#000000
#FFFFFF
5
#000000
#FFFFFF
Shares in Bayer fell dramatically in the wake of a court ordering its unit Monsanto to pay out $289 million in damages in a cancer trial. (Photo: Mike Mozart/Flickr/cc)
With Merger Pending, Bayer Shares Plunge After Court Orders Monsanto to Pay $289 Million to Cancer Victim
The nosedive comes as groups say nearly-finalized merger threatens consumers, farmers, and planet
Aug 13, 2018
Shares in Bayer took a nosedive on Monday--just days after newly-acquired Monsanto was ordered to pay $289 million in damages to a man who alleged that the company's glyphosate-based herbicides, including the widely used weedkiller Roundup, caused his cancer.
At one point the German pharmaceutical giant's shares fell by as much as 14 percent, Reuters reported, marking a loss in value of roughly $14 billion.
It capped off the U.S. trading day as one of the "biggest losers," ending at a 10-percent loss.
Friday was also a losing day for Monsanto, which Bayer AG controversially acquired for $62.5 billion in June. In a landmark trial, a San Francisco jury unanimously found that the company failed to warn school groundskeeper Dewayne Johnson, who's suffering from non-Hodgkin's lymphoma, and other consumers of the cancer risks from its weed killers, and said the company acted "with malice or oppression."
The International Agency for Research on Cancer (IARC)--a branch of the World Health Organization (WHO)--classified glyphosate as a probable human carcinogen, but Monsanto says its Roundup is safe, and that it plans on appealing.
Monday also marked the last day of the public comment period for the finalization of the merger process, prompting a broad range of advocacy groups to voice their opposition once again.
"No matter how you cut it," said said Daniel Raichel, an attorney with the Nature Program at NRDC, "a Bayer/Monsanto merger spells higher costs for farmers and locks in the chemical-heavy agricultural practices that threaten our health and the bees and other pollinators critical to food security."
"The Department needs to reverse course and block the merger before we all suffer the consequences," he said.
We are at a crossroads
This country and this world are at a monumental crossroads. US voters have an opportunity to beat back the forces of fascism and confront the billionaires who are rigging the economy, our media system, and our democracy, making it increasingly impossible for ordinary people to get by. We’re not just talking about the election. We’re talking about what must be done once these fascist elements are vanquished from power. We need a bolder set of solutions than what either major party has so far been willing to offer and a working-class movement ready to fight like hell for it. Trump didn't emerge from nowhere. The conditions that fueled MAGA authoritarianism were created by decades of radical neoliberal economic policies and a corrupt political system dominated by corporate interests. They slashed taxes on the super-rich, promising that the benefits would trickle down. They said giveaways to the corporate titans would make life more affordable for the rest of us. It was all bullshit. And when a bitter, betrayed populace searches for someone to blame, right-wing demagogues have little trouble finding scapegoats. People know when they're being lied to, but you won't hear any of this from the corporate media. Only independent journalism—powered and funded by people who believe in building a better world—can deliver truly trustworthy daily news. If you share our vision, please contribute whatever you can to sustain our work. |
Our work is licensed under Creative Commons (CC BY-NC-ND 3.0). Feel free to republish and share widely.
Shares in Bayer took a nosedive on Monday--just days after newly-acquired Monsanto was ordered to pay $289 million in damages to a man who alleged that the company's glyphosate-based herbicides, including the widely used weedkiller Roundup, caused his cancer.
At one point the German pharmaceutical giant's shares fell by as much as 14 percent, Reuters reported, marking a loss in value of roughly $14 billion.
It capped off the U.S. trading day as one of the "biggest losers," ending at a 10-percent loss.
Friday was also a losing day for Monsanto, which Bayer AG controversially acquired for $62.5 billion in June. In a landmark trial, a San Francisco jury unanimously found that the company failed to warn school groundskeeper Dewayne Johnson, who's suffering from non-Hodgkin's lymphoma, and other consumers of the cancer risks from its weed killers, and said the company acted "with malice or oppression."
The International Agency for Research on Cancer (IARC)--a branch of the World Health Organization (WHO)--classified glyphosate as a probable human carcinogen, but Monsanto says its Roundup is safe, and that it plans on appealing.
Monday also marked the last day of the public comment period for the finalization of the merger process, prompting a broad range of advocacy groups to voice their opposition once again.
"No matter how you cut it," said said Daniel Raichel, an attorney with the Nature Program at NRDC, "a Bayer/Monsanto merger spells higher costs for farmers and locks in the chemical-heavy agricultural practices that threaten our health and the bees and other pollinators critical to food security."
"The Department needs to reverse course and block the merger before we all suffer the consequences," he said.
Shares in Bayer took a nosedive on Monday--just days after newly-acquired Monsanto was ordered to pay $289 million in damages to a man who alleged that the company's glyphosate-based herbicides, including the widely used weedkiller Roundup, caused his cancer.
At one point the German pharmaceutical giant's shares fell by as much as 14 percent, Reuters reported, marking a loss in value of roughly $14 billion.
It capped off the U.S. trading day as one of the "biggest losers," ending at a 10-percent loss.
Friday was also a losing day for Monsanto, which Bayer AG controversially acquired for $62.5 billion in June. In a landmark trial, a San Francisco jury unanimously found that the company failed to warn school groundskeeper Dewayne Johnson, who's suffering from non-Hodgkin's lymphoma, and other consumers of the cancer risks from its weed killers, and said the company acted "with malice or oppression."
The International Agency for Research on Cancer (IARC)--a branch of the World Health Organization (WHO)--classified glyphosate as a probable human carcinogen, but Monsanto says its Roundup is safe, and that it plans on appealing.
Monday also marked the last day of the public comment period for the finalization of the merger process, prompting a broad range of advocacy groups to voice their opposition once again.
"No matter how you cut it," said said Daniel Raichel, an attorney with the Nature Program at NRDC, "a Bayer/Monsanto merger spells higher costs for farmers and locks in the chemical-heavy agricultural practices that threaten our health and the bees and other pollinators critical to food security."
"The Department needs to reverse course and block the merger before we all suffer the consequences," he said.
We've had enough. The 1% own and operate the corporate media. They are doing everything they can to defend the status quo, squash dissent and protect the wealthy and the powerful. The Common Dreams media model is different. We cover the news that matters to the 99%. Our mission? To inform. To inspire. To ignite change for the common good. How? Nonprofit. Independent. Reader-supported. Free to read. Free to republish. Free to share. With no advertising. No paywalls. No selling of your data. Thousands of small donations fund our newsroom and allow us to continue publishing. Can you chip in? We can't do it without you. Thank you.
To inform. To inspire. To ignite change for the common good.
News & Opinion
Trending
Common Dreams, Inc. Founded 1997. Registered 501(c3) Non-Profit
Privacy Policy